Pharmacokinetics of BF2.649 in Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bioprojet
Related studies linked through entity extraction aliases.
Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)
- Status
- COMPLETED
- Phase
- PHASE3
BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.
- Status
- COMPLETED
- Phase
- PHASE3
BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Study to Demonstrate Cognitive Enhancing Effects of BF2.649
- Status
- COMPLETED
- Phase
- PHASE2
Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2